Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) have recently risen to a new 52-week high. The stock has been seen at $34.45 after a recent session check. Over the last 5 trading periods, the stock has seen a move of 0.19%.EPS Watch
Revance Therapeutics, Inc. (NASDAQ:RVNC)’s EPS growth this year is -5.20% and the trailing 12-month EPS is $-3.81. Covering sell-side analysts are estimating company growth for next year to be 6.60%. On a consensus basis, analysts have given a recommendation of 1.90 on company shares.
Since the start of the calendar year, Revance Therapeutics, Inc. (NASDAQ:RVNC)’s stock has changed 25.60%. Over the last five trading sessions, the stock has moved 0.19%. For the past month, Revance Therapeutics, Inc.’s stock has been 0.39%, 5.91% for the last quarter, 8.79% for the past six months and 46.07% for the past 52 weeks.
Based on current stock levels, Revance Therapeutics, Inc. shares are trading 19.83% off of the 50-day high and 43.54% away from the 50-day low.
Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples.